Stocks making the biggest moves premarket: Robinhood, Boeing, Moderna & more

Boeing rose 2% premarket after winning a $20 billion U.S. Defense Department contract to develop the Sixth-Generation F/A-XX Strike Fighter, while rival Northrop Grumman fell 3.5%. Robinhood gained 2% after unveiling an in-app AI trading agent and plans for 24/7 stock trading and U.S. perpetual futures. Earnings-related weakness pressured Concentrix (-9.5%) on a revenue miss and below-consensus outlook, while Cal-Maine (-6.5%) posted a $1.26-per-share loss versus an expected $0.77 loss; Moderna fell more than 6% following a Citi downgrade with a target 60% below its prior close.

Analysis

BA’s defense win improves program relevance and backlog quality, but the market should not capitalize the headline contract value as near-term revenue: development programs are typically margin-dilutive early and carry execution, cost-overrun, and fixed-price risk. The more investable implication is relative—NOC loses a visible aircraft franchise opportunity, potentially increasing its dependence on classified programs and missile/space budgets; the BA/NOC spread should widen over 1-3 months if budget commentary confirms funding durability. BA’s commercial cash-flow recovery remains the dominant equity driver, so a defense-led rally without improved delivery and free-cash-flow milestones is vulnerable.

FORM is a cleaner second-order AI beneficiary than broad semiconductor beta if advanced packaging, HBM, and GPU complexity raise test-content-per-unit. Its position as an alternative probe-card source creates upside from supplier diversification at TSM, but the thesis requires evidence of revenue mix and gross-margin expansion rather than a research-note-driven multiple rerating; NVDA demand alone does not guarantee FORM capture. Over 6-18 months, test intensity can remain structurally favorable even if leading-edge wafer volumes pause.

CNXC’s revenue pressure is a warning that enterprise AI adoption can initially cannibalize outsourced service-seat volumes faster than it produces higher-value implementation revenue. This favors software and infrastructure vendors monetizing AI directly over labor-arbitrage business-process outsourcers; a weak guide is more consequential than a single-quarter miss because it challenges the terminal-margin framework. HOOD’s product expansion raises engagement and asset-gathering optionality, but perpetual futures introduce regulatory, volatility, and credit-loss risk; the equity remains more sensitive to retail-risk appetite and crypto volumes than to product announcements.

Key Decisions for Investors

• Initiate a 1-3 month BA/NOC pair: long BA, short NOC in equal beta-adjusted dollars. Target 8-12% relative return if defense-budget follow-through supports BA while NOC’s lost platform optionality is repriced; stop if BA commercial delivery/FCF guidance deteriorates or NOC announces a compensating classified award.
• Accumulate FORM only on confirmation of next earnings guidance showing AI-related test-content growth and stable-to-higher gross margin; use a 6-12 month horizon. A suitable structure is long FORM versus a partial SOXX hedge, with thesis invalidated by TSM customer concentration worsening, probe-card share loss, or a semiconductor-capex downgrade.
• Maintain or establish a 3-6 month short CNXC versus long a diversified AI software/infrastructure basket such as IGV or MSFT. The expected driver is estimate cuts from seat-volume cannibalization; cover if bookings, implementation revenue, or margin guidance demonstrates that AI is net-accretive sooner than expected.
• Do not chase HOOD on the announcement. Set an alert for sustained improvement in net deposits, options/crypto trading activity, and regulatory clearance details before adding exposure; regulatory restrictions on U.S. perpetual futures or a retail-volatility drawdown would sharply impair the near-term catalyst.